- Home
- ARCT vs SABA Comparison
ARCT vs SABA Comparison
Compare ARCT & SABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCT
- SABA
- Stock Information
- Founded
- ARCT 2013
- SABA 1988
- Country
- ARCT United States
- SABA United States
- Employees
- ARCT N/A
- SABA N/A
- Industry
- ARCT Biotechnology: Pharmaceutical Preparations
- SABA
- Sector
- ARCT Health Care
- SABA
- Exchange
- ARCT Nasdaq
- SABA Nasdaq
- Market Cap
- ARCT 320.8M
- SABA 257.3M
- IPO Year
- ARCT N/A
- SABA N/A
- Fundamental
- Price
- ARCT $17.32
- SABA $9.19
- Analyst Decision
- ARCT Strong Buy
- SABA
- Analyst Count
- ARCT 10
- SABA 0
- Target Price
- ARCT $50.88
- SABA N/A
- AVG Volume (30 Days)
- ARCT 536.4K
- SABA 290.0K
- Earning Date
- ARCT 11-06-2025
- SABA 01-01-0001
- Dividend Yield
- ARCT N/A
- SABA 12.91%
- EPS Growth
- ARCT N/A
- SABA N/A
- EPS
- ARCT N/A
- SABA N/A
- Revenue
- ARCT $122,122,000.00
- SABA N/A
- Revenue This Year
- ARCT N/A
- SABA N/A
- Revenue Next Year
- ARCT $31.09
- SABA N/A
- P/E Ratio
- ARCT N/A
- SABA N/A
- Revenue Growth
- ARCT N/A
- SABA N/A
- 52 Week Low
- ARCT $8.04
- SABA $3.64
- 52 Week High
- ARCT $25.88
- SABA $4.42
- Technical
- Relative Strength Index (RSI)
- ARCT 54.49
- SABA 45.86
- Support Level
- ARCT $17.38
- SABA $9.13
- Resistance Level
- ARCT $18.69
- SABA $9.23
- Average True Range (ATR)
- ARCT 1.00
- SABA 0.09
- MACD
- ARCT -0.11
- SABA -0.01
- Stochastic Oscillator
- ARCT 44.23
- SABA 26.09
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.
About SABA Saba Capital Income & Opportunities Fund II Shares of Beneficial Interest
Saba Capital Income & Opportunities Fund II is a closed-end fund. The company seeks high current income, with a secondary goal of capital appreciation. The fund invests in fixed income markets across the globe.